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Abstract  28 
Developmental nicotine exposure causes persistent changes in cortical neuron 29 
morphology and in behavior. We used microarray screening to identify master 30 
transcriptional or epigenetic regulators mediating these effects of nicotine and discovered 31 
increases in Ash2l, a component of a histone methyltransferase complex. We therefore 32 
examined genome-wide changes in H3K4 tri-methylation, a mark induced by the Ash2l 33 
complex associated with increased gene transcription. A significant number of regulated 34 
promoter sites were involved in synapse maintenance. We found that Mef2c interacts 35 
with Ash2l and mediates changes in H3K4 tri-methylation. Knockdown of Ash2l or 36 
Mef2c abolishes nicotine-mediated alterations of dendritic complexity in vitro and in vivo, 37 
and attenuates nicotine-dependent changes in passive avoidance behavior. In contrast, 38 
overexpression mimics nicotine-mediated alterations of neuronal structure and passive 39 
avoidance behavior. These studies identify Ash2l as a novel target induced by nicotinic 40 
stimulation that couples developmental nicotine exposure to changes in brain epigenetic 41 
marks, neuronal structure and behavior. 42 
43 
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 44 
High affinity nicotinic acetylcholine receptors (nAChRs) are involved in early 45 
brain development, nicotine-mediated alterations of neuronal structure, and persistent 46 
changes in behavior 1,2. Developmental nicotine exposure induces structural and synaptic 47 
changes in the developing brain 3 and these changes persist into later life 4. Accordingly, 48 
developmental exposure to nicotine is associated with many deleterious effects, including 49 
deficits in learning and later development of psychiatric disorders 5-7; however, the 50 
molecular mechanisms underlying these effects of cholinergic signaling on early brain 51 
development are largely unknown. 52 
We used microarray screening to detect long-term changes in gene expression 53 
with the goal of identifying pleiotropic master transcriptional regulators responsible for 54 
persistent morphological alterations of cortical neurons. Among identified genes that 55 
could alter a transcriptional program, a component of a histone methylase complex, Ash2l, 56 
was significantly up-regulated by nicotine exposure during development. We therefore 57 
used next generation sequencing to determine whether nicotine could alter histone 58 
methylation associated with promoter regions of ensembles of genes involved in neuronal 59 
structure. Developmental nicotine exposure induced significant enrichment of 60 
trimethylated histone 3, lysine 4 (H3K4me3) at promoter regions of multiple genes 61 
involved in development and maintenance of excitatory synapses, including the 62 
transcription factor Mef2c, which assembles with Ash2l in a histone methyltransferase 63 
complex. Taken together, this study identifies a novel role for Ash2l in the regulation of 64 
neuronal morphology during early brain development and a new molecular mechanism 65 
underlying the long-term consequences of developmental nicotine exposure.  66 
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 67 
Results 68 
Developmental nicotine treatment alters neuronal morphology  69 
 Exposure to tobacco smoke during human development can alter cortical 70 
structure as measured by diffusion tensor imaging (DTI) 8. Since nicotine can alter 71 
dendritic spine number and neuronal morphology 1, we determined whether nicotine in 72 
tobacco smoke could underlie changes in cortical fractional anisotropy (FA) measured by 73 
DTI. Among regimens used to deliver nicotine during development 7, drinking water 74 
administration results in significant blood levels in the dam and the offspring and has 75 
minimal stressful effects 9. We therefore exposed mice to saccharin or nicotine (200 76 
μg/ml) from the time of conception through weaning (P21) and measured FA at 3 months 77 
of age. This regimen results in persistent neurochemical and behavioral changes in 78 
exposed pups, with no effects on maternal behavior 10. Developmental nicotine exposure 79 
induced significant increases in FA in a number of cortical areas, largely in gray matter 80 
(Fig. 1a, b).  To determine whether changes in gray matter such as spine density and 81 
dendritic arborization underlie increased FA, we labeled neurons diolistically with DiI 82 
and performed Sholl analysis and spine counting in mice exposed to nicotine throughout 83 
pre- and postnatal development as in the DTI study, as well as in an additional group that 84 
was treated only from birth to weaning (postnatal exposure), a critical period for cortical 85 
development dependent on acetylcholine signaling 11. Nicotine significantly increased 86 
spine density in both the pre- and postnatal nicotine treated group and in the postnatal-87 
only nicotine treated group (Fig. 1c). There was a significant effect of nicotine treatment 88 
on dendritic complexity across rostral, medial and caudal regions of cortex (Fig. 1d-f), 89 
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and across all cortical layers, as demonstrated by a significant nicotine treatment by 90 
dendritic complexity interaction in each cortical layer compared to the saccharin-treated 91 
group (Fig. 1g-i). These results are consistent with previous studies showing that nicotine 92 
can induce persistent changes in spine density 3,4. Postnatal-only nicotine treated mice 93 
also showed a significant increase in dendritic complexity across all cortical regions and 94 
layers (supplementary Fig. 1). 95 
 96 
Nicotine induces a histone methyltransferase protein 97 
In order to identify persistent changes in transcriptional regulation that might be 98 
responsible for the effects of developmental nicotine treatment on cortical neuron 99 
morphology, we performed microarray analysis on mRNA prepared from dissected 100 
cortical tissue from mice administered saccharin or nicotine throughout the pre- and 101 
postnatal period until P21, that were then allowed to remain nicotine-free until 3 months 102 
of age (Fig. 2a; GEO accession #GSE80789). Our goal was to identify master 103 
transcriptional regulators that might maintain a program of gene expression responsible 104 
for persistent changes in neuronal morphology many weeks after developmental exposure 105 
to nicotine. We identified 18 probe sets that were significantly different between 106 
developmental nicotine-treated and control animals (Fig. 2b; supplementary Fig. 2a). To 107 
determine whether these changes in gene expression were an immediate or a later 108 
consequence of developmental nicotine exposure, we evaluated mRNA levels in 109 
independent cortical tissue samples by qRT-PCR immediately after nicotine exposure (21 110 
days postnatal; Fig. 2c) or in adulthood following cessation of nicotine exposure (3 111 
months postnatal; supplementary Fig 2b). At P21, 9 probes identified in the microarray 112 
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study were significantly induced compared to the control group using qRT-PCR, 113 
including Ash2l, Chsy3, Ntrk2, Zfp91, Zcchc11, Cep192, Alkbh1, Ctnnal1, and Tmem107 114 
(Fig. 2c). Five out of 15 probes initially identified by microarray were significantly 115 
different as measured by qRT-PCR compared to the control group at 3 months of age. 116 
These included Ash2l, Chsy3, Zcchc11, Cep192, and Tmem107. Among these, Ash2l was 117 
the most highly regulated by two regimens of developmental nicotine treatment (Fig. 2d, 118 
e) and met our criterion as a master regulator of transcription as measured in muscle 119 
development 12. Ash2l belongs to the trithorax (trx) gene family, a positive regulator of 120 
gene transcription particularly critical for development and cell differentiation through 121 
trimethylation of H3K4me3 13.  122 
Histone methylation provides a potential mechanism for long-term regulation of 123 
gene expression that could maintain the effects of early nicotine exposure into adulthood. 124 
We therefore evaluated H3K4me3 across the genome in cortical tissue following pre- and 125 
postnatal (Fig. 3a) and postnatal-only (Fig. 3b) nicotine exposure and identified 14,881 126 
gene loci (Fig. 3a, b; GEO accession # GSE80789). Short read sequences from the 127 
ELAND pipeline were performed for quality control, and those that did not meet criteria 128 
for fidelity were discarded. Identified peaks were viewed in Genome browser and their 129 
alignment was verified (examples shown in Fig. 3c). 367 differentially-enriched peaks 130 
with adjusted p values < 0.05 were identified in cortical samples from pre- and postnatal 131 
nicotine exposed mice, and 426 differentially enriched peaks were identified from 132 
postnatal-only exposed mice (Fig. 3d; supplementary Tables 1 and 2).  133 
Developmental nicotine exposure altered histone methylation at genomic sites 134 
responsible for the regulation of synapses, postsynaptic plasticity and cell junctions as 135 
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identified by gene ontology (GO) analysis (using adjusted p values < 0.05; supplementary 136 
Tables 3 and 4). The genomic sites in these GO categories are highly overlapping 137 
(supplementary Fig. 3a). Most of the genomic sites identified in this screen are implicated 138 
in glutamatergic synaptic transmission (Grin1, Grin2c and Grin2d NMDA receptor 139 
subunits), and synapse formation (Dlg2, Camk2a, and Dlgap2). 140 
Although there was substantial overlap in genomic sites associated with increased 141 
histone methylation in both nicotine-treated groups, developmental nicotine exposure 142 
resulted in different effects depending on time and duration of exposure.  We identified 143 
common genomic sites from gene lists (adjusted p value < 0.05) of differentially enriched 144 
histone methylation following pre- and postnatal or postnatal-only nicotine exposure 145 
(example regulated locus; supplementary Fig. 3b). A total of 39 genes showed 146 
overlapping changes in both the pre- and postnatal and postnatal-only nicotine treated 147 
group (supplementary Tables 1 and 2).  148 
In order to validate these changes, all 36 overlapping genomic sites (excluding 3 149 
Riken genes with unknown function) were tested using chromosome 150 
immunoprecipitation (ChIP) followed by qPCR in independent samples. 34 of 36 tested 151 
genomic sites showed significant changes in associated H3K4me3 levels in the pre- and 152 
postnatal or postnatal-only groups compared to the control group (Fig. 3e, supplementary 153 
Fig. 3c).  154 
 155 
Nicotine increases histone methylation at the Mef2c locus  156 
Consistent with our search for master transcriptional regulators, we selected 157 
Mef2c for further functional characterization from among the 34 genomic sites that were 158 
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verified by ChIP-PCR because the Mef2 family has been identified as part of the 159 
methylation complex along with Ash2l 12, and also participates in dendritic remodeling 160 
during neural differentiation 14,15. We first determined whether identified Ash2l and 161 
Mef2c binding sites in the genome 16 overlap with the sites of differentially enriched 162 
H3K4me3 sites we found following developmental nicotine exposure. A large proportion 163 
of Ash2l (mouse ES cell dataset) and Mef2c (early neuronal activity-induced cortical 164 
neuron datasets) binding sites overlapped with the H3K4me3 sites found here 165 
(supplementary Fig. 3d). GO analysis of these 6426 overlapping genomic sites (those 166 
sites differentially enriched as a result of nicotine exposure that overlapped with 167 
previously identified sites of Ash2l and Mef2c binding) identified synapse-related genes 168 
as a significant category (supplementary Fig. 3d). This suggested that Ash2l and Mef2c 169 
may normally interact at genomic sites related to synaptic function during neuronal 170 
development and induce histone tri-methylation and transcription of these loci, and that 171 
this complex is modulated as a result of developmental exposure to nicotine.  172 
Mef2c expression is normally up-regulated during neuronal differentiation and 173 
maturation 14,15. Although it was not identified in our initial microarray screen, it is likely 174 
that the genome-wide evaluation missed some upregulated targets due to stringent 175 
statistical cut-offs. We therefore used targeted analyses to determine whether the mRNA 176 
encoding Mef2c is regulated following nicotine exposure during development. Using 177 
qPCR, we found that Mef2c mRNA levels were significantly elevated in the cortex of 178 
mice treated with nicotine throughout development (supplementary Fig. 4a). Mef2c 179 
genomic sites also showed significantly elevated H3 acetylation (supplementary Fig. 4b), 180 
an additional histone modification related to increased transcription.  181 
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At 3 months of age, H3K4me3 association with the Mef2c locus was elevated 182 
across all regions of cortex as measured by ChIP-PCR following developmental nicotine 183 
exposure, although changes were somewhat more modest in the caudal region 184 
(supplementary Fig. 4c). These data confirm that histone changes at the Mef2c locus are 185 
maintained for a long period following nicotine exposure, and that changes in histone 186 
methylation and gene expression occur broadly across cortical regions.  187 
 188 
Ash2l and Mef2c expression levels are regulated by nAChRs 189 
In vivo genome-wide screening can identify loci that may be relevant for long-190 
term consequences of developmental nicotine exposure, but cannot distinguish between 191 
direct effects of nicotine and indirect changes of downstream pathways. To determine 192 
whether alterations of Ash2l and Mef2c levels are due to direct effects of nicotine 193 
mediated through nAChRs, Ash2l and Mef2c protein levels were evaluated in cultured 194 
neural progenitor cells. After 8-9 days in culture, neural progenitor cells had 195 
differentiated into neurons. Cells were treated with nicotine (1 μM) for 48 h and protein 196 
levels were evaluated by Western blotting. Nicotine exposure significantly increased 197 
Mef2c and Ash2l protein levels as compared to saline treatment (Fig. 4a, b). The 198 
involvement of nAChR activity in the effects of nicotine on Mef2c and Ash2l expression 199 
was verified by exposure to the nicotinic antagonists mecamylamine, α-bungarotoxin, 200 
dihydro-β-erythroidine (DHβE) and methyllycaconitine (MLA; Fig. 4a, b). 201 
Mecamylamine and DHβE significantly attenuated nicotine-induced increases in Ash2l 202 
and Mef2c protein levels, whereas α-bungarotoxin and MLA had little effect, suggesting 203 
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that heteromeric (likely α4/β2 subunit containing) nAChRs are more likely to contribute 204 
to these effects than homomeric nAChRs containing the α7 subunit. 205 
Nicotine depolarizes neurons and increases levels of intracellular calcium, leading 206 
to induction of intracellular signaling cascades. To study the role of calcium signaling in 207 
nicotine-dependent alterations in Ash2l and Mef2c levels, we grew neural progenitor cells 208 
for 8-9 days, then treated with nifedipine (10 μg/ml) for 48 h with or without nicotine. 209 
Co-treatment with nifedipine blocked the effects of nicotine and significantly reduced 210 
basal levels of Ash2l and Mef2c (Fig. 4a, b), suggesting that expression of these proteins 211 
is calcium-dependent and could be induced by depolarization.  212 
Direct interaction of Mef2c and Ash2l was next assessed by co-213 
immunoprecipitation using a Mef2c antibody to pull down Ash2l (Fig. 4c). Ash2l was 214 
recognized in samples immunoprecipitated with the specific Mef2c antibody, but much 215 
less Ash2l was observed in the control condition. Thus, Ash2l and Mef2c form a complex 216 
in neural progenitor cells, as has been documented in muscle cells 12. We next determined 217 
whether additional methyltransferase complex subunits (Wdr5, Mll, Rbbp5) that form a 218 
complex with Ash2l in muscle were also present in neural progenitor cells. Wdr5 and 219 
Rbbp5 were detected following formalin cross-linking and immunoprecipitation of Ash2l 220 
at baseline, and levels of Wdr5 were significantly elevated following treatment of cells 221 
with nicotine (Fig. 4d). Thus, the methyltransferase complex is expressed in neural 222 
progenitors and multiple components are regulated by nicotine signaling. 223 
 224 
Ash2l/Mef2c mediate nicotine effects on dendrite morphology  225 
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If the Ash2l/Mef2c complex is involved in transcriptional regulation of genes 226 
involved in synapse and spine formation, these proteins may be necessary for the ability 227 
of nicotine to induce changes in dendritic structure. To determine whether Ash2l and 228 
Mef2c are involved in dendritic spine formation, we generated shRNAs specific for 229 
mouse Ash2l or Mef2c and transfected these into neural progenitor cells. Down-regulation 230 
of Ash2l or Mef2c protein was confirmed by Western blotting (supplementary Fig. 5). 231 
Neural progenitor cells were transfected with Ash2l shRNA, Mef2c shRNA or scrambled 232 
control shRNA (Fig. 5a-f) and exposed for 4 days to saline or nicotine. Four days of 233 
nicotine exposure significantly increased the number of spines on dendritic shafts of 234 
cultured neurons (Fig. 5a, b). Conversely, knockdown of Ash2l or Mef2c (Fig. 5a, b) 235 
significantly reduced the number of dendritic spines on apical dendrites of cultured neural 236 
progenitor cells and abolished the increase in spines induced by 4 days of nicotine 237 
exposure. 238 
To determine whether the Ash2l/Mef2c complex could also be critical for effects 239 
of nicotine on cortical neuron structure in vivo, in utero electroporation was used to 240 
introduce the shRNAs targeting Ash2l or Mef2c into a subset of neurons in the cortex of 241 
mice at embryonic day 14 (E14). Control (scrambled) shRNA was electroporated into the 242 
right hemisphere of a subset of the developing embryos and Ash2l or Mef2c shRNA was 243 
electroporated into the left hemisphere of remaining littermates (supplementary Fig. 6). 244 
Dams were administered nicotine or saccharin in the drinking water starting from the day 245 
of surgery and pups were euthanized on postnatal day 21 for analysis of cortical neuron 246 
dendritic structure. Exposure to nicotine increased dendritic complexity in neurons 247 
expressing the scrambled construct, whereas knockdown of Ash2l or Mef2c abolished the 248 
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ability of nicotine exposure to alter dendritic branching (Fig. 5c-e). Consistent with the 249 
possibility that the Ash2l/Mef2c complex mediates the effects of nicotine on dendritic 250 
structure, overexpression of Ash2l or Mef2c mimicked the ability of nicotine to increase 251 
dendritic complexity in the absence of drug exposure (Fig. 5f). 252 
Similarly, electroporation of the Ash2l shRNA abolished the ability of nicotine to 253 
increase density of dendritic spines (Fig. 5g). Unexpectedly, knockdown of Mef2c 254 
resulted in significantly increased basal spine density compared to control animals; 255 
however, there was no further increase in spine density by nicotine exposure following 256 
Mef2c knockdown (Fig. 5g). These results suggest that Mef2c signaling likely has 257 
multiple roles in spine formation and stabilization 14,17-22, but among those roles, it 258 
contributes to the ability of nicotine to increase spine number. In contrast, 259 
overexpression of Ash2l or Mef2c increased spine density (Fig. 5h). 260 
 261 
Ash2l/Mef2c mediate nicotine effects on passive avoidance 262 
Knockdown of Ash2l or Mef2c in vivo prevents developmental nicotine-induced 263 
remodeling of dendritic morphology and spine density. In previous studies, we showed 264 
that nicotine exposure during the first 3 postnatal weeks induces hypersensitive passive 265 
avoidance learning in response to a subthreshold foot shock that is normally ignored 23,24. 266 
Furthermore, this effect is mediated through β2 subunit-containing nAChRs on 267 
corticothalamic neurons. We hypothesized that this behavioral consequence of 268 
developmental nicotine exposure could result from morphological changes in sensory 269 
cortex as a result of Ash2l and Mef2c induction. We tested passive avoidance behavior in 270 
mice following shRNA-mediated knockdown or cDNA overexpression of Ash2l or Mef2c 271 
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in sensory cortex via in utero electroporation. While we targeted sensory cortex based on 272 
the DTI findings and the role of sensory stimuli in passive avoidance behavior, all 273 
animals showed broad cortical expression of the shRNA constructs, and some expression 274 
was seen bilaterally. Mice were exposed to saccharin or nicotine from the time of surgery 275 
until weaning on postnatal day 21 (Fig. 6a).  As predicted, nicotine-exposed mice 276 
demonstrated hypersensitive passive avoidance performance, as shown by increased 277 
latency to enter a dark chamber paired with a mild foot shock, compared to saccharin-278 
exposed mice (Fig. 6a). Cortical delivery of Ash2l or Mef2c shRNA by in utero 279 
electroporation significantly attenuated the hypersensitive passive avoidance induced by 280 
nicotine (Fig. 6a). Despite this significant attenuation, Ash2l knockdown did not 281 
completely abolish the effects of nicotine, likely due to incomplete knockdown or 282 
variability in cortical targeting. Finally, Ash2l or Mef2c overexpression via 283 
electroporation mimicked the effect of nicotine exposure, resulting in hypersensitive 284 
passive avoidance behavior as compared to controls (Fig. 6b), demonstrating 285 
bidirectional modulation of passive avoidance by Ash2l and Mef2c. 286 
 287 
Discussion 288 
The current results demonstrate that Ash2l and Mef2c are critical for the ability of 289 
nAChR activity to alter cortical neuron architecture and behavior during development. 290 
We propose that nicotine-dependent induction of the Ash2l/Mef2c complex during 291 
cortical development induces alterations of histone methylation associated with promoter 292 
regions of genes involved in structure and function of glutamatergic synapses, and 293 
increases spine number, dendritic branching and hypersensitive passive avoidance 294 
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behavior, a task modulated by nAChRs expressed in cortical neurons. Together, these 295 
results identify a molecular mechanism underlying the ability of nAChRs to influence 296 
synaptic and dendritic structure and provide a potential cellular mechanism underlying a 297 
persistent behavioral consequence of developmental nicotine exposure.  298 
Among the small number of genes that are persistently regulated in adulthood 299 
following early nicotine exposure, we focused on Ash2l because it fit the profile of a 300 
protein that could maintain a broad program of gene expression changes into adulthood. 301 
Ash2l is the mammalian homolog of ash2, a gene that belongs to the trithorax (trx) gene 302 
family and is a positive regulator of homeotic genes through DNA binding 25 and 303 
maintenance of chromatin in a transcriptionally active conformation 26. The Ash2l gene is 304 
highly conserved across evolution and functions as a transcription factor 27. It is a subunit 305 
of several Trx complexes that associate with the Set1 family of histone H3K4 306 
methyltransferases 28. Decreased expression of Ash2l impairs histone H3K4 307 
trimethylation (H3K4me3) and expression of SET family target genes 29. 308 
In mammals, Ash2l is expressed in fetal human and mouse brain and its 309 
expression decreases in adult tissue 30. A study of alcohol-induced changes in brain gene 310 
expression identified changes in trx-related genes, including Ash2l 31, suggesting that 311 
modulation of Ash2l may also be important for effects of alcohol and other drugs on brain 312 
development. Based on the human proteome atlas database, Ash2l protein in brain is 313 
detected only in neuronal and glial cells of the cerebral cortex and cerebellum 32. We 314 
cannot exclude the possibility that Ash2l signaling in glial cells is involved in nicotine 315 
effects on cortical morphology or behavior; however, the in utero electroporation studies 316 
may indicate that this is unlikely. Electroporation into the cortex at E14 largely targets 317 
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pyramidal neurons because GABA interneurons have not yet migrated from the 318 
ganglionic eminence at E14, whereas astroglia develop later and electroporated DNA is 319 
diluted by the time glia start to differentiate 33. In addition, the genes most significantly 320 
regulated by nicotine exposure during development fall into neuronally-relevant GO 321 
groups, including those involved in glutamatergic synaptic formation and maintenance. 322 
Taken together, these observations support a primary role for Ash2l and Mef2c in 323 
neuronal signaling following nicotine exposure during development.  324 
This study also identifies a novel mechanism of gene regulation during brain 325 
development that could be more generally involved in activity-dependent structural 326 
changes of cortical neurons. Ash2l-mediated changes in H3K4me3, specifically at 327 
promoters of genes involved in synapse maintenance, likely reflect transcriptional 328 
alterations at these loci during a critical period of development that become fixed in the 329 
genome 34. H3K4me3 has been identified as an active promoter mark 35 and may regulate 330 
formation of the pre-initiation complex and gene transcription by interacting with other 331 
transcription factors 36.  332 
Of the 34 promoter regions associated with H3K4me3 changes following nicotine 333 
exposure, the Mef2c locus is of particular interest because interaction between Ash2l and 334 
Mef2d selectively induces trimethylation of H3K4, which subsequently induces gene 335 
expression changes required for muscle differentiation 12. While Mef2c mRNA levels 336 
increase in parallel with the increase in H3K4me3 associated with its promoter, it is not 337 
yet known whether these histone methylation changes alter Mef2c expression directly. In 338 
myoblasts undergoing terminal differentiation, p38α-dependent phosphorylation 339 
of Mef2d recruits the Ash2l complex to myogenic gene promoters, enhancing histone 340 
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H3K4 methylation 12, promoting formation of the transcription initiation complex and 341 
recruiting associated transcription factors that maintain the expression of myogenic genes 342 
37. Thus, the enrichment of H3K4me3 and persistence of elevated Ash2l expression many 343 
weeks after developmental nicotine exposure may maintain transcription of loci 344 
associated with H3K4me3 enrichment into adulthood.  345 
Although differential H3K4me3 enrichment is positively correlated with 346 
transcription of specific subsets of genes, it is weakly correlated with genome wide 347 
transcription changes. The involvement of H3K4me3 in specific gene expression changes 348 
is therefore still somewhat controversial. The current study showing differential 349 
enrichment of histone methylation at genomic sites following developmental nicotine 350 
exposure may suggest that this subset of promoter regions is among those activated by 351 
the H3K4me3 mark. While the mechanisms that distinguish genomic loci transcribed as a 352 
result of this histone methylation event are not yet clear, the ability of nicotinic signaling 353 
to stimulate synaptically-related loci may help identify components of the complex that 354 
confer specific transcriptional activation. We note that although a small subset of loci 355 
were significantly enriched by both pre- and postnatal and postnatal-only nicotine 356 
exposure compared to saccharin treatment, 99% of loci identified with the H3K4me3 357 
mark were identified in both nicotine treatment groups. The two regimens of nicotine 358 
exposure resulted in differential enrichment of H3K4me3 patterns across this set of gene 359 
loci, likely because histone methylation changes are highly dynamic across this period of 360 
neural precursor differentiation resulting in a cumulative representation of changes at 361 
each stage of development. Thus, the subset of gene loci showing differential H3K4me3 362 
enrichment common to the two regimens of nicotine exposure are likely to be those loci 363 
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most critical for the functional effects of nicotine on adult neuronal morphology and 364 
behavior.  365 
Surprisingly, most of the genes implicated in developmental response or 366 
neuroadaptation to nicotine are implicated in glutamatergic neurotransmission, synaptic 367 
structure or spine formation. In addition to its role in the Ash2l complex, the Mef2 family 368 
is involved in synaptic maturation and dendritic structure 14,17-22. Members of the Mef2 369 
family are expressed throughout the developing central nervous system 38 and can 370 
regulate activity-dependent synaptic morphogenesis in hippocampal neurons 39,40. Mef2c 371 
regulates gene expression 18,19 and facilitates neuronal plasticity by regulating synaptic 372 
number and function in adult rodents 14. The identification of mutations in genes 373 
regulated by the Mef2 family in human neurological diseases, including autism spectrum 374 
disorders, suggests that Mef2 activity is critical for normal brain development. 375 
Conditional knockout of the Mef2c gene in mouse brain results in changes in neuronal 376 
density, disorganized cortical structure and immature electrophysiological properties, 377 
along with abnormalities in anxiety-like behaviors and cognitive tasks 21. The current 378 
results support the idea that Mef2c plays multiple roles in neuronal development, some of 379 
which are dependent on Ash2l and others that are likely to be independent.  380 
Although loci with synapse-related functions were most clearly identified by gene 381 
ontology analysis following developmental nicotine exposure, genomic sites in the 382 
channel binding protein and activity modulator groups were also identified, including a 383 
number of calcium and potassium channel subunits (see supplementary Tables 3 and 4). 384 
In addition, developmental nicotine administration induced changes in histone 385 
methylation of acetylcholine receptor loci, including the α3 subunit of the nAChR 386 
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(Chrna3) and the muscarinic subunit M1 (Chrm1). Thus, developmental nicotine 387 
exposure has persistent effects on histone structure of loci associated with glutamatergic 388 
synaptic transmission, neuronal excitability and cholinergic signaling, and common 389 
molecular and cellular changes can be induced by different durations of nicotine exposure.  390 
The early postnatal weeks appear to be a critical period for nicotine-induced 391 
molecular, cellular and behavioral alterations. The first 2-3 weeks of postnatal 392 
development in the mouse corresponds to the third trimester of human pregnancy with 393 
respect to cortical synaptic development 41,42. Previous studies suggest that stimulation of 394 
nAChRs and the resulting calcium influx contributes to maturation of glutamatergic 395 
synapses 11 and stimulation of β2* nAChRs induces spine formation in hippocampal and 396 
cortical neurons in a cell-autonomous manner 1. In previous studies we have shown that 397 
developmental nicotine exposure during the first three weeks of postnatal development 398 
induces persistent hypersensitive passive avoidance behavior that lasts into adulthood 23,24. 399 
Increased passive avoidance learning in response to a mild footshock that is normally 400 
ignored could represent an inability to screen out irrelevant sensory stimuli, consistent 401 
with the increased incidence of attentional disorders in children exposed in utero to 402 
maternal smoking 7. Maternal smoking is also associated with increased smoking in adult 403 
offspring, although this is not modeled with the passive avoidance paradigm. The 404 
hypersensitive passive avoidance phenotype requires expression of β2* nAChRs on layer 405 
6 corticothalamic neurons, consistent with the finding that manipulation of Ash2l or 406 
Mef2c levels in cortex can modulate passive avoidance learning.  407 
The correlation between the ability of the Ash2l/Mef2c complex to regulate 408 
nicotine-dependent remodeling of dendritic morphology and changes in passive 409 
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avoidance behavior suggest that the alterations in neuronal structure may mediate a 410 
persistent behavioral consequence of early nicotine exposure. The current study provides 411 
a novel molecular mechanism that underlies these cellular and behavioral consequences 412 
of nicotine administration. Moreover, the fact that DTI has the sensitivity to detect these 413 
morphological changes of dendritic spine density provides clinical opportunities to 414 
evaluate these changes in behaving human subjects. In addition to mediating the effects 415 
of developmental exposure to the nicotine in tobacco, these molecular mechanisms likely 416 
contribute to normal brain development, suggesting that dysregulation of cholinergic 417 
induction of Ash2l and Mef2c as a result of genetic or environmental factors could 418 
increase the risk for neurodevelopmental disorders such as attention deficit hyperactivity 419 
disorder 5-7.  420 
 421 
422 
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Figure Legends 582 
Figure 1 – Morphological changes in cortical neurons induced by developmental 583 
nicotine exposure. Voxel-based analysis of FA changes induced by nicotine treatment 584 
during development measured by DTI (diagram from the Paxinos atlas 43 identifies 585 
affected regions). Two-tail t-tests of average FA values in nicotine and saccharin groups 586 
indicate a significant difference (n = 5 brains/condition; t(23) = 3.310, p =  0.00305573) 587 
in cortical regions investigated, including (a) somatosensory cortex and (b) sensory 588 
cortex. (c) Nicotine significantly increases spine density in nicotine treated groups 589 
compared to controls (pre- and postnatal: Sac (n = 26 slices from 6 mice), Nic (n = 25 590 
slices from 5 mice), t49 = 5.151, p = 0.00000460; postnatal-only: Sac (n = 19 slices from 6 591 
mice), Nic (n = 29 slices from 6 mice), t46 = 4.961, p = 0.00001002). (d-i) The number of 592 
intersections was assessed for the apical dendritic tree. Scale bar = 12 μm. (d) Frontal (F) 593 
cortical regions: (F(1,113) = 9.019, p = 0.00329026). The (e) parietal (P) and (f) occipital 594 
(O) regions of cortex showed a significantly higher number of intersections following 595 
nicotine exposure compared to the control group. (e) F(1,48) = 31.924; p = 0.00000085. 596 
(f) F(1,38) = 32.082, p = 0.00000165. (g-i) Layer-specific effects of developmental 597 
nicotine exposure on dendritic complexity. (g) Superficial layers of cortex showed the 598 
least change in complexity of dendritic arbors following early nicotine exposure (F(1,33) 599 
= 20.835, p = 0.0000661). Layers (h) 3/4 (F(1,85) = 25.927, p = 0.00000210) and (i) 5/6 600 
(F(1, 30)=17.452, p = 0.00020270) show significant nicotine-induced increases in 601 
dendritic arborization compared to the control group. *, p < 0.05. Frontal (Sac, n = 41; 602 
Nic, n = 73), Parietal (Sac, n = 29; Nic, n = 23), Occipital (Sac, n = 23; Nic, n = 25), L1/2 603 
(Sac, n = 20; Nic, n = 15), L3/4 (Sac: Sac, n = 36 ; Nic, n = 53), L5/6 (Sac, n = 14; Nic, 604 
n=18). “n” represents number of slices from 6 mice. Error bars represent s.e.m. 605 
 606 
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Figure 2 – Nicotine exposure during development alters expression of a gene 607 
involved in histone methylation. (a) Schematic of developmental nicotine exposure 608 
regimens. (b) List of the 18 probes that were significantly different between 609 
developmentally-treated and untreated animals. Primers (see supplementary Table 5) 610 
corresponding to 15 identified probes (excluding unannotated and predicted transcribed 611 
probe sets) were used to evaluate mRNA changes in cortical tissue from a separate set of 612 
animals using qRT-PCR. (c) 9 of 15 probe sets were significantly altered in independent 613 
samples immediately after the cessation of developmental nicotine treatment at 21 days 614 
of age (*p < 0.05; Ash2l: F(1,8) = 10.848, p = 0. 01096250; Chsy3: F(1,8) = 31.334, p = 615 
0.00051163; Zfp91: F(1,8) = 14.28, p = 0.00539670; Cflar: F(1,8) = 1.83, p = 616 
0.21311592; Zcchc11: F(1,8) = 5.49, p = 0.04718863; Cep192: F(1,8) = 30.084, p = 617 
0.00058407; Gmeb1: F(1,8) = 0.416, p = 0.53699305; Alkbh1: F(1,8) = 16.474, p = 618 
0.00363940; Unc13b: F(1,8) = 0.416,  p = 0.53699305; Duox1: F(1,8) = 1.19, p = 619 
0.30709203; Scula2: F(1,8) = 1.58, p = 0.24421686; Zfp597: F(1,8) = 2.15, p = 0.181; 620 
Ctnnal1: F(1,8) = 13.878, p = 0.00582675; Ntrk2: F(1,8) = 13.364, p = 0.00644127; 621 
Tmem107A : F(1,8) = 28.897, p = 0.00066513). Ash2l mRNA levels were significantly 622 
elevated following exposure to nicotine during development (d) immediately following 623 
nicotine exposure (21 days of age; F(3,16) = 6.898, p = 0.003411) and (e) in adulthood (3 624 
months of age; F(3,16) = 10.736, p = 0.000413) in samples from mice treated throughout 625 
the pre- and postnatal period or during the postnatal period only. (*p <0.05; *** p <0.01 626 
with multiple comparisons; # p <0.05). A total of 20 mice (Nic: n = 10; Sac, n = 10) were 627 
used for microarray studies. 5 animals were pooled for each experimental group and two 628 
replicate experiments were analyzed. 2 or 3 animals were pooled for each sample for 629 
qPCR analysis and 5 samples per each condition were analyzed (21 days: Nic: n = 13; 630 
Sac, n = 15. 3 months: Nic: n = 11; Sac, n = 15).  Whiskers represent minimum to 631 
maximum value of data distribution.   632 
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Figure 3 – Differential enrichment of H3K4me3 at promoter sites associated with 633 
synapse function following developmental nicotine exposure. (a,b) Scatterplots of 634 
relative enrichment level, degree of (fold) change, and P values (nominal p value cutoffs) 635 
of all 14,881 identified genomic sites in the pre- and postnatal, and postnatal-only, 636 
nicotine treated groups. Dots in red indicate genomic loci for which adjusted. p < 0.05 (c) 637 
Genome browser tracks of H3K4me3 epigenetic marks at four selected genomic sites 638 
(Litaf, Rabgab1l, Sepsecs, and Ank1). Images were acquired using igvtools integrated 639 
genome browser and confirmed with UCSC genome browser. The peak distribution 640 
pattern of each replicate of a representative locus is shown in supplementary Fig. 3b. (d) 641 
ChIP-seq analysis identified 367 differentially enriched peaks in cortical samples from 642 
mice exposed to nicotine during the pre- and postnatal periods, and 426 differentially 643 
enriched peaks in cortical samples from mice exposed to nicotine only in the postnatal 644 
period, with adjusted p values < 0.05. (e) Verification of identified gene loci that were 645 
enriched following both nicotine exposure regimens using ChIP-PCR showed that 36 of 646 
39 genomic sites identified in the ChIP-seq analysis were differentially methylated in 647 
independent samples following pre- & postnatal nicotine exposure compared to the 648 
control group (*, p < 0.05; ***, p < 0.01 with multiple comparisons; #, p < 0.05; Gapdh: 649 
F(1,8) = 0.00, p = 1.000; Eif4a: F(1,8) = 31.364, p = 0.00051003; Izumo: F(1,6) = 0.900, 650 
p = 0.37940979; Gpr19: F(1,8) = 9.107, p = 0.01661552; Litaf: F(1,8) = 5.554, p = 651 
0.04619611; kcnq1: F(1,8) = 0.792, p = 0.39946656; Lage3: F(1,8) = 16.418, p = 652 
0.00367444; Fbxw4: F(1,8) = 17.9, p = 0.00287307; Fgf12: F(1,7) = 13.804, p = 653 
0.00750159; Sepsecs: F(1,8) = 7.568, p = 0.02502024; Rin2: F(1,8) = 33.897, p = 654 
0.00039509; Rabgap1l: F(1,8) = 11.344, p = 0.00981340; Ano2: F(1,8) = 107.443, p = 655 
0.00000649; Apool: F(1,8) = 120.782, p = 0.00000418; Lipc: F(1,8) = 893.328, p = 656 
0.00000001; Cdk5rap: F(1,8) = 23.198, p = 0.00132739; Ing4: F(1,8) = 10.019, p = 657 
0.01328880; Ank3: F(1,8) = 11.424, p = 0.00964250; Ntm: F(1,7) = 330.474,  p = 658 
0.00000038; Zfp658: F(1,7) = 141.861, p = 0.00000669; csda: F(1,8) = 8.411, p = 659 
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0.01988645; Sorcs1: F(1,7) = 5.378, p = 0.05346909; Lars2: F(1,7) = 23.081, p = 660 
0.00195662; Ank1: F(1,7) = 47.436, p = 0.00023397; Acacb: F(1,7) = 128.527, p = 661 
0.00000930; Mgda2: F(1,7) = 10.811, p = 0.01333907; Chl1: F(1,7) = 18.662, p = 662 
0.00348039; Auts2: F(1,8) = 11.318, p = 0.00986976; : F(1,8) = 29.295 Mbnl1, p = 663 
0.00063647; : F(1,8) = 141.042 Cpeb1, p = 0.00000232; Zfp71-rs1: F(1,8) = 830.025, p 664 
= 0.0000001; Chd9: F(1,8) = 396.42, p = 0.00000004; Syt4: F(1,8) = 87.029, p = 665 
0.00001422; Sp110: F(1,8) = 7.628, p = 0.02460310; Sorbs2: F(1,8) = 77.526, p = 666 
0.00002176; Slc35a2: F(1,8) = 37.6, p = 0.00027950; Mef2c: F(1,8) = 10.881, p = 667 
0.01088096).  Each replicate was a pool of 2-4 brain samples and 5 replicates were used 668 
for each condition (Sac: n = 5 pools from 17 animals; Nic: n = 5 pools from 15 animals). 669 
Whiskers represent minimum to maximum value of data distribution.  670 
 671 
Figure 4 – The Ash2l/Mef2c complex is regulated by nAChR activity. (a, b) Nicotine 672 
treatment of neural progenitor cells in culture significantly elevated Ash2l (a) and Mef2c 673 
(b) protein levels (F(13,42) = 12.540, p = 0.000001 (Saline vs Nic: p = 0.009350; α-BTX 674 
vs α-BTX+Nic: p = 0.003186; MLA vs MLA+Nic: p = 0.000001; Atropine vs 675 
Atropine+Nic: p = 0.000030) and F(13,42) = 3.749, p = 0.000551 (Saline vs Nic: p = 676 
0.023076; α-BTX vs α-BTX+Nic: p = 0.010348; MLA vs MLA+Nic: p = 0.05; Atropine 677 
vs Atropine+Nic: p = 0.023488), respectively, as measured by one-way ANOVA 678 
followed by LSD test for multiple comparisons). This was reversed by the broad 679 
spectrum nAChR antagonist mecamylamine (MEC) and the more selective heteromeric 680 
nAChR antagonist dihydro-β-erythroidine (DHβE). The selective α7 nAChR antagonists 681 
α-bungarotoxin (btx) and methyllyccaconitine (MLA) had no effect on their own and did 682 
not alter the effects of nicotine (Nic). The voltage-gated calcium channel blocker 683 
nifedipine (Nif) decreased levels of Ash2l and Mef2c at baseline and abolished the ability 684 
of nicotine to increase their expression. (c) Ash2l and Mef2c can be co-685 
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immunoprecipitated in a complex from neural progenitor cells (replicated twice). (d) Wdr 686 
5 protein levels are increased by nicotine treatment. n = 4 replicates per condition for all 687 
neural progenitor experiments. Original Western blots presented in supplementary Fig. 7. 688 
Whiskers represent minimum to maximum value of data distribution.  689 
 690 
Figure 5 – The Ash2l/Mef2c complex mediates dendritic remodeling by nicotine in 691 
neural progenitor cells and in vivo.  (a, b) shRNAs targeting Ash2l or Mef2c were 692 
transfected into neural progenitor cells and spine density was measured on the apical 693 
dendrite in control cells (Saline) or following 4 days of exposure to nicotine in the bath 694 
(Nicotine). Nicotine-induced increases in spine density are significantly attenuated by 695 
Ash2l shRNA and Mef2c shRNA delivery (F(5,108)=28.45, p=0.000001 with LSD 696 
correction for multiple comparisons). Scrambled Saline vs. Scrambled Nicotine: p = 697 
0.000001; Scrambled shRNA: Saline, n = 20, Nicotine, n=13; Ash2l shRNA: Saline, n = 698 
26, Nicotine = 11; Mef2c shRNA: Saline, n = 17, Nic = 11. “n” sizes for neural 699 
progenitor studies represent total cells counted across 3 independent cultures. Scale bar = 700 
18 μm. (c - f) shRNAs or overexpression constructs for Ash2l and Mef2c were introduced 701 
into the developing cortex at E14 by electroporation, with or without nicotine treatment. 702 
(c) Representative images of cortical neurons following nicotine treatment or 703 
electroporation of shRNA constructs (supplementary Fig. 6 shows extent of construct 704 
spread). (d) Nicotine exposure during the first 21 days of postnatal development 705 
increased the complexity of cortical neuron dendrites as measured by Sholl analysis (F(1, 706 
174) = 14.570, p = 0.0002) and this was blocked by electroporation of shRNAs targeting 707 
Ash2l into the developing cortex at E14. Gene x treatment interaction: F(1, 174) = 16.633, 708 
p = 0.00006893 by two-way ANOVA with repeated measures followed by Tukey’s test 709 
for multiple comparisons (Scrambled Saccharin (n = 32) vs. Scrambled Nicotine (n = 57): 710 
p = 0.000581, Ash2l Saccharin (n = 22) vs. Ash2l Nicotine (n = 67): p = 0.229149. “n” 711 
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sizes for in vivo studies represent number of slices from 5 mice.  (e) Nicotine-mediated 712 
changes in dendritic complexity are abolished by electroporation of Mef2c shRNA into 713 
developing cortex. Gene x treatment interaction: F(1,110) = 95.076, p = 0.0000001 by 714 
two-way repeated measures ANOVA with repeated measures followed by Tukey’s test 715 
for multiple comparisons (Scrambled Saccharin (n = 26) vs. Scrambled Nicotine (n = 31): 716 
p = 0.000581, Ash2l Saccharin (n = 27) vs. Ash2l Nicotine (n = 30): p = 0.229149). (f) 717 
Overexpression of Ash2l or Mef2c increases dendritic complexity (F(2,71) = 100.450, p = 718 
0.0000001 by one-way ANOVA with repeated measures). OE control (n = 28) vs. OE 719 
Ash2l (n = 22): p = 0.0000001; OE control (n = 28) vs. OE Mef2c (n = 24): p = 720 
0.0000001 with Tukey’s test for multiple comparisons.  (g) Nicotine-induced increases in 721 
spine density are significantly attenuated by electroporation of Ash2l or Mef2c shRNAs 722 
into developing cortex (F(5,183) = 10.748, p = 0.0000001 with LSD test for multiple 723 
comparisons). Scrambled Saccharin vs. Scrambled Nicotine: p = 0.0000001; Scrambled 724 
Saccharin vs. Mef2c Saccharin: p = 0.042553; Scrambled Saccharin vs. Mef2c Nicotine: p 725 
= 0.023182; Scrambled Nicotine vs. Mef2c Saccharin: p = 0.000158; and Scrambled 726 
Nicotine vs. Mef2c Nicotine: p = 0.000295. Scrambled shRNA: (Sac, n = 21; Nic, n = 36). 727 
Ash2l shRNA: (Sac, n = 34; Nic, n = 37). Mef2c shRNA: (Sac, n = 23; Nic, n = 38). (h) 728 
Overexpression of Ash2l or Mef2c significantly increases spine density increases 729 
(F(2,102) = 19.692, p = 0.00000006 with LSD test for multiple comparisons). OE control 730 
(n = 34) vs. OE Ash2l (n = 45): p = 0.000033; OE control (n = 34) vs. OE Mef2c (n = 26): 731 
p = 0.019220. Differences measured by one-way ANOVA followed by LSD test for 732 
multiple comparisons. Whiskers represent minimum to maximum value of data 733 
distribution.  Error bars represent s.e.m.  734 
 735 
Figure 6 – Developmental nicotine-induced changes in passive avoidance behavior 736 
require expression of Ash2l and Mef2c.  (a) Nicotine treatment from E14 through P21 737 
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induces hypersensitive passive avoidance behavior that is attenuated by knockdown of 738 
Ash2l or Mef2c (F(5,135) = 2.759; p = 0.02090053, LSD correction for multiple 739 
comparisons). Scrambled Saccharin vs. Scrambled Nicotine: p = 0.015343; Ash2l Saline 740 
vs. Ash2l Nicotine: p = 0.009136 with LSD multiple comparison test. Scrambled shRNA: 741 
(Sac, n = 19; Nic, n = 24). Ash2l shRNA: (Sac, n = 10; Nic, n = 60). Mef2c shRNA: (Sac, 742 
n = 13; Nic, n = 15). F(5,130) = 2.713; p = 0.023 (b) Overexpression of Ash2l or Mef2c 743 
induces hypersensitive passive avoidance behavior (F(2,82) = 8.858; p = 0.00031264, 744 
LSD correction for multiple comparisons). OE-control vs. OE-Ash2l: p = 0.000076; OE-745 
control vs. OE-Mef2c: p = 017160 with LSD multiple comparison test). OE, control: (n = 746 
31), OE, Ash2l: (n = 22), OE, Mef2c: (n = 32). (c) Representative images of an in utero 747 
electroporated mouse brain. Efficiency of electroporation was variable but expression 748 
was consistently spread broadly across the parietal cortex. Error bars represent s.e.m.  749 
 750 
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 Online Methods 755 
 Animals 756 
All procedures were approved by the Yale University Institutional Animal Care 757 
and Use Committee and conformed to the standards of the NIH Guide for Care and Use 758 
of Laboratory Animals. C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME) used in 759 
the developmental nicotine exposure studies acclimated for 1 week, had ad libitum food 760 
and water and a 12-h light–dark cycle (lights on at 7AM). 761 
 762 
Reagents 763 
Nicotine hydrogen tartrate (Sigma, St Louis, MO, USA) was dissolved in 764 
phosphate-buffered saline (PBS) pH 7.4 and placed at −20°C until use. Inhibitors were 765 
incubated with the cultures for the following durations before nicotine stimulation: 766 
mecamylamine (20 min; Sigma), α-bungarotoxin (α-BTX; 20 min; Sigma and 767 
Calbiochem) and nifedipine (15 min; Sigma). Most inhibitors were used at a stock 768 
concentration of 1000X of the desired stimulating concentration. Anti-Ash2l antibody 769 
(abcam, ab176334) and anti-Mef2c antibody (Cell Signaling, 5030) were validated using 770 
cells overexpressing Ash2l and Mef2c. Anti-Wdr5 antibody (Abcam, ab56919) and anti-771 
Rbbp5 antibody (Abcam, ab52084) have been validated in published studies 772 
(supplementary methods checklist). Anti-β tubulin antibody (Abcam, ab6046) and anti-773 
Gapdh antibody (Sigma, G8795-200UL) were used as loading controls for Western blots 774 
and have been validated in published studies (supplementary methods checklist). 775 
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 776 
Developmental Nicotine Exposure 777 
After vaginal plug identification, gestating mice were singly housed with ad 778 
libitum access to food and water containing 200 μg/ml nicotine hydrogen tartrate 779 
(calculated as free base) in 2% (w/v) saccharin or pH-matched 2% saccharin with 780 
0.2% (v/v) tartaric acid (Sigma-Aldrich, St Louis, MO). Solutions were prepared twice a 781 
week. At 21 days, offspring were weaned and left undisturbed until brain tissue 782 
harvesting except for routine husbandry. Female mice were used for genome wide 783 
screening, structural analyses and biochemical studies described below and animals were 784 
randomly assigned to treatment groups for all studies. 785 
 786 
Diffusion tensor imaging (DTI) and analysis  787 
The DTI datasets were obtained using a custom-made 43 H radio frequency 788 
volume coil (40mm diameter) on a 9.4T horizontal bore magnet (Bruker, Billerica, MA, 789 
USA) The DTI experiments were performed using the Stejskal-Tanner spin-echo 790 
diffusion-weighted sequence with a diffusion gradient of 5 ms and a delay between the 791 
two diffusion gradients of 15 ms as previously described 44. Briefly, twenty contiguous 792 
coronal slices of 0.5 mm thickness were acquired with a repetition time of 2 s and an 793 
echo time of 25.1 ms. Two 1ms Shinnar–Le Roux (SLR) pulses were used for excitation 794 
and inversion, respectively. Eighteen averages were acquired and the 128 × 64 images 795 
were zero-filled to 256 × 256, resulting in an in-plane resolution of 100 μm × 100 μm. 796 
Sixteen different images were acquired for each slice, fifteen corresponding to 797 
noncollinear diffusion weighting directions (b=1000 s/mm2) and one with no diffusion 798 
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weighting. In addition, a 256 x 256 fast spin-echo anatomical image was acquired for 799 
each brain with the same slice geometry and position as the DTI images. The anatomical 800 
image was used for registration of each individual brain to a common reference image. 801 
The diffusion tensor was calculated from the intensities of the 16 diffusion-802 
weighted images and the tensor eigenvalues (λ1, λ2 and λ3) were obtained by matrix 803 
diagonalization. The fractional anisotropy (FA) was calculated using the following 804 
equation: 805 
ܨܣ = ඨ32
ሺߣଵ − ߣଶሻ + ൫ߣଶ − ߣ௔௩௚൯ + ൫ߣଷ − ߣ௔௩௚൯
ߣଵଶ + ߣଶଶ + ߣଷଶ  
where λavg = (λ1 + λ2 + λ3)/3. The fast spin-echo anatomical images were non-rigidly 806 
registered to a reference isotropic anatomical image (100 µm) using a non-linear 807 
intensity-based warping parameterized in terms of a tensor b-spline grid with uniform 808 
control point spacing of 1.5 mm. These transformations were used to warp the smoothed 809 
FA (Gausian smoothing sigma=0.2 mm) maps to the same isotropic reference anatomical 810 
image at 100µm resolution. The mean and the standard deviation FA maps for both 811 
nicotine and saccharin groups were then calculated. To measure the differences between 812 
the two groups, two tail t-test maps were generated from the mean and standard deviation 813 
FA maps. The t-test maps were used to define brain regions (Fig. 1a), for which the mean 814 
FA difference becomes significant (p<0.05). An average FA value was calculated first for 815 
each individual brain in each of these regions. Then, an average FA value and the 816 
corresponding standard deviation in these regions were calculated for nicotine and 817 
saccharin groups separately.  818 
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 819 
Diolistic labeling of cortical neurons in mouse brain slices  820 
Tungsten particles (1.3 µm diameter, Bio-Rad, Berkeley, CA) were coated with 821 
the lipophilic carbocyanine dye DiI (Invitrogen, Calrsbad, CA). DiI-coated particles were 822 
delivered diolistically into tissue at 120 psi using a Helios Gene Gun system (Bio-Rad, 823 
Berkeley, CA) fitted with a polycarbonate filter (3.0 µm pore size; BD Biosciences, 824 
Franklin Lakes, NJ). DiI was allowed to diffuse along neuronal dendrites and axons in 825 
PBS for 16 - 24 h at 4°C, and then labeled sections were fixed again in 4% 826 
paraformaldehyde for 1 h. After brief washing in PBS, sections were mounted with 827 
Fluoromount G mounting media (Electron Microscopy Sciences, Hatfield, PA) onto glass 828 
slides (Thermo Scientific, Waltham, MA). 829 
 830 
Confocal imaging and three-dimensional reconstructions  831 
Cortical pyramidal neurons were imaged using an UltraVIEW VoX spinning disc 832 
confocal microscope with a 60x CFI Plan Apo objective and equipped with a Hamamatsu 833 
C9100-50 camera, with excitation at 561 nm. Z-stacks were collapsed into projection 834 
images and 2- 3 neurons/brain were manually analyzed per section.   835 
 836 
Neuronal tracing and data analysis 837 
Cortical regions were identified using stereotactic coordinates according to the 838 
Paxinos mouse brain map 1: Frontal cortex: Bregma +1 mm; Parietal cortex: Bregma   -839 
2.06 mm; Occipital cortex: Bregma -2.46 mm (from rostral to caudal). Pyramidal neurons 840 
from layers 1/2, layer 3/4, and layer 5/6 of entire cortex with complete cellular and 841 
dendritic staining were selected for analysis.  For apical spine density quantitative 842 
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analysis, collected data were processed for reconstruction with NeuronStudio software as 843 
described in the manufacturer’s manual (CNIC, Mt. Sinai School of Medicine, New York, 844 
NY; http://research.mssm.edu/cnic/help/ns/index.html). A 200 μM segment of the apical 845 
dendritic branch was analyzed. Maximum and minimum spine length was set at < 3.5 μm 846 
and > 0.5 μm respectively. After automatic detection of spines by the NeuronStudio 847 
software, spots that were not on the quantified dendrite were removed manually. For 848 
Sholl analysis of apical dendritic arborization, Simple Neurite Tracer (SNT) software was 849 
used. SNT is open source software, licensed under the GNU General Public License and 850 
based on the public domain image processing software ImageJ. To build a simple path, 851 
successive points were selected along the midline of a neural process, and the software 852 
would automatically find a path between them. Connected neural processes were 853 
confirmed by generating a 3D reconstruction image.  854 
The morphological parameters measured for each apical dendrite and complexity 855 
of dendritic arborization were measured using Sholl analysis with NeuronStudio software 856 
(MicroBrightField) by calculating the number of crossings that intersected defined 857 
concentric circles spaced 10 μm-apart starting from the center of cell body as a function 858 
of distance from the soma and is based on a total of 214 neurons from 6 animals in the 859 
pre- & postnatal nicotine treated group and 181 neurons from 5 animals in the postnatal-860 
only nicotine treated group. All data were collected by an investigator blinded to 861 
condition.  862 
 863 
Microarray analysis 864 
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Mouse tissue samples were cut into slices less than 1 mm in thickness, transferred 865 
to Trizol reagent (Invitrogen, Carlsbad, CA) and disrupted with a Dounce tissue 866 
homogenizer (Wheaton, Millville, NJ). An equal volume of chloroform was added and 867 
samples were centrifuged for 5 min (4°C, 12,000g). The aqueous phase was transferred to 868 
a column from an RNeasy tissue kit (Qiagen, Redwood City, CA) and RNA was isolated 869 
according to the manufacturer's recommendations. Subsequently, RNAs from 4 animals 870 
were pooled to obtain 5 pools per experimental group (20 subjects total). Generation of 871 
double-stranded cDNA, preparation and labeling of cRNA, hybridization to GeneChip® 872 
Mouse Genome 430 2.0 Arrays (Affymetrix, Santa Clara, CA) and washing was 873 
performed according to the standard Affymetrix protocol. Data analysis was performed 874 
using different R packages from the Bioconductor project (www.bioconductor.org). 875 
Microarray experiments were done on sample sizes based on successful experiments in 876 
the literature. All confirmation experiments were performed on multiple pools of brain 877 
samples to reduce biological variability and provide adequate statistical power. 878 
 879 
Chromatin Immunoprecipitation (ChIP) 880 
Mouse tissue samples (50 mg) were cut into slices less than 1 mm in thickness, 881 
and fixed in 3 ml of 1% formaldehyde/PBS solution for 10 min at room temperature to 882 
cross-link chromatin DNA and proteins. After being washed with PBS, the tissue samples 883 
were homogenized in a glass-Teflon homogenizer. Following homogenization, chromatin 884 
was isolated using the Magna ChIP G kit (Millipore, Temecula, CA) according to the 885 
Millipore protocol. Briefly, cells were lysed in Cell Lysis Buffer in the presence of 886 
protease inhibitor cocktail. Nuclei were isolated from the lysed cells by centrifugation, 887 
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and resuspended in Nuclear Lysis Buffer. The chromatin DNA was then fragmented into 888 
150 – 500 base-pair range by sonication using a Branson Sonifer (Danbury, Connecticut).  889 
To immuno-precipitate specific genomic regions of chromatin DNA, the isolated 890 
chromatin fragments were incubated with antibodies against histone H3 trimethylated at 891 
Lysine 4 (H3K4-me3, Abcam, Cambridge, MA) and magnetic protein G beads 892 
(Millipore) at 4o C for 2.5 hr. Following incubation, the beads were washed with low salt, 893 
high salt, LiCl salt, and TE buffers, and chromatin fragments were reverse cross-linked 894 
by proteinase K digestion at 62o C for 2 hr.  895 
The eluted DNA was purified after reverse cross-linking by column purification. 896 
H3k4me3-specific enrichment was validated by PCR amplification of select positive and 897 
negative genomic regions and amplification signals were normalized to the input DNA 898 
samples which were extracted from the same pools of chromatin fragments without 899 
enrichment by immunoprecipitation. To control for any differences in DNA across 900 
conditions, all ChIP-PCR data were normalized to GAPDH. 901 
 902 
High-throughput, massively parallel sequencing 903 
Sample preparation and sequencing on the Genome Analyzer (Illumina, San 904 
Diego, CA) were carried out according to the Illumina protocols with some modifications. 905 
Briefly, the double stranded cDNA and ChIP-enriched genomic DNA were treated with 906 
T4 DNA polymerase and the Klenow fragment for end repair. The 5’ ends of the DNA 907 
fragments were then phosphorylated by T4 polynucleotide kinase, and an adenosine base 908 
was added to the 3’ end of the fragments by Klenow (3’-5’ exo). A universal adaptor was 909 
then added to both ends of the DNA fragments by A-T ligation. Following 18 cycles of 910 
 42
PCR with the Phusion DNA polymerase, the DNA library was then purified on a 2% 911 
agarose gel, and fragments of 170 – 300 base-pair in size were recovered. Around 15 ng 912 
of the DNA library was then used for cluster generation on a grafted GAII Flow Cell, and 913 
then sequenced on the Genome Analyzer for 36 cycles using the “Sequencing-by-914 
synthesis” method. 915 
 916 
Sequence base-calling, mapping to genome, data normalization and statistical analysis 917 
Sequences were called from image files with the Illumina Genome Analyzer 918 
Pipeline (GApipeline) and aligned to the reference genome (UCSC mm9) using Extended 919 
Eland in the GApipeline. Uniquely mapped H3K4-me3 reads for each sample were 920 
retrieved from export.txt files (output of Extended Eland). Based on their mapping 921 
locations, these selected reads were parsed with in-house Perl scripts to generate base 922 
coverage in WIG file format. After moving average smoothing, the chromosome 923 
locations of enrichment peaks were identified from pooled WIG files using in-house Perl 924 
scripts. 925 
The uniquely aligned reads by ELAND pipeline were considered in calling peaks. 926 
To eliminate noise and account for unequal total numbers, we used a defined analysis 927 
model (Model-based Analysis of ChIP-Seq, MACS 45) with default parameters to find 928 
peaks, which were called “peaks” of H3K4me3. For comparison analysis, a customized 929 
genomic interval file was created for EdgeR 46 analysis. 930 
Gene Ontology analysis was performed by using the Functional Annotation Tool 931 
of the DAVID Bioinformatics Resources 6.7, National Institute of Allergy and Infectious 932 
Diseases (NIAID), NIH (http://david.abcc.ncifcrf.gov/). Statistical methods were not used 933 
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to predetermine sample sizes, but ‘n’ sizes were based on other published studies. All 934 
confirmation experiments were performed on multiple pools of brain samples to reduce 935 
biological variability and provide adequate statistical power.  936 
 937 
 938 
Cell culture 939 
Neural progenitor cell cultures were generated from C57BL/6J mice at embryonic 940 
day 15 as described in the Cold Spring Harbor protocol for neural progenitor cell culture 941 
5. Each embryonic mouse brain was placed in a clean dish containing ice-cold 1X PBS. 942 
Brains were separated into two hemispheres, followed by separation of the dorsal 943 
telencephalon. Isolated brain regions were carefully transferred to a non-treated 944 
polystyrene dish containing cold 1X PBS and tissue was disrupted with a Pasteur pipette. 945 
Papaine Enzyme solution prepared as described in protocol 47 was added and incubated 946 
for 20 min at 37°C. Neural progenitor cell media (NEP) was added after adding enzyme 947 
inhibitor solution and centrifugation. Cells were counted using a hemacytometer and 948 
4x106 cells were added to a non-treated culture dish containing NEP medium with EGF 949 
and bFGF (NEP complete medium). Once spheres formed, neural spheres were 950 
transferred to a PDL and laminin coated culture dish. The next day, after the neural 951 
spheres settled and attached to the culture dish, NEP complete medium was replaced with 952 
NEP medium containing 1% horse serum. For histological analysis, shRNA constructs 953 
were introduced into cells at DIV 8/9 when progenitor cells had already differentiated 954 
into neurons, and cultures then underwent a further 4 days of exposure to nicotine or 955 
saline. Histological analyses were performed at DIV 12/13. 956 
 44
 957 
Western blotting 958 
Approximately 40 μg of each sample was separated by 10% SDS–polyacrylamide 959 
gel electrophoresis and transferred to nitrocellulose membranes. Blots were blocked with 960 
5% milk in Tris-buffered saline with 0.05% (v/v) Tween-20 (TBS-T) for 60 min at 25°C, 961 
washed three times in TBS-T for 15 min, and then incubated at 4°C overnight in primary 962 
antibody diluted in TBS-T. Blots were washed three times in TBS-T and incubated for 963 
60 min at 25°C in secondary antibody in TBS with 0.1% Tween. Blots were washed three 964 
times in TBS-T and two times in water before scanning with an Odyssey Infrared 965 
Scanner (Li-Cor Biosciences, Lincoln, NE, USA). The scans were performed with the 966 
following scan parameters: intensity = 5.0, for each wavelength (700 and 800 nm), 967 
resolution = 169, quality = medium, and focus offset = 0 mm. The scanned intensity of 968 
the two secondary antibodies’ fluorophores was then used by the Odyssey Software v1.2 969 
(Li-Cor Biosciences) to produce individual images for each wavelength, and a 970 
pseudocolor overlay of the 700 (red) and 800 nm (green) scans. The area of each band 971 
was selected for quantification and the integrated intensity of the 700 and 800 nm 972 
wavelengths was measured using Odyssey Software without investigator manipulation. 973 
Since Li-Cor uses the absolute intensities for quantitation, the pseudocolor images are 974 
reflections of the absolute value measured by the program. The integrated intensity 975 
values were then exported to Excel (Microsoft, Redmond, WA, USA) for further analysis. 976 
For Ash2l expression detection, Chemiluminescence (ECL detection kit from GE health 977 
care, Pittsburgh, PA, USA) was used.   978 
 979 
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Immunoprecipitation assay 980 
Approximately 4 x 106 neural progenitor cells (NPCs) were treated with nicotine 981 
or PBS. Following treatment, NPCs were lysed in Ripa buffer (0.7 % Na-Deoxycholate, 982 
500 mM LiCl, 50mM HEPES-KOH, pH 7.6, 1% NP-40, 1mM EDTA). Samples were 983 
sonicated and protein was measured using a D/C protein assay kit (Bio-rad). 500-1000 ug 984 
of protein was used for each immunoprecipitation assay. The anti-H3K4me3 antibody 985 
(Millipore) was coupled to Protein-A beads (Novex Lifetechnologies) and 986 
immunoprecipitation and elution were performed according to the manufacturer’s 987 
recommendation.  988 
 989 
Design and construction of shRNAs 990 
shRNAs targeting Ash2l and Mef2c were constructed by selecting unique 24 base 991 
or 19 base sequences in the consensus coding region of the mRNA encoding the different 992 
isoforms of Ash2l and Mef2c (Ash2l; GenBank accession NM_011791.3, Mef2c; 993 
GenBank accession  NM_025282.3) as previously described 48. A random sequence of 24 994 
bases without similarities to any known mRNA was selected for the scrambled shRNA. 995 
Synthetic oligonucleotide duplexes were designed as previously described.  Annealed 996 
oligonucleotides were ligated into a pAAV-EGFP-shRNA vector as described previously 997 
and positive clones were verified by sequencing 48-50. Sequences of shRNAs were as 998 
follows: Ash2l shRNA (5’ to 3’: 1. GTGCCATCACAGTGGGAATACCTA; 2. 999 
GCCATCACAGTGGGAATACCTACT; 3. CCGGAAGCAAGCAAATTTA). 1000 
Mef2c shRNA (5’ to 3’: 1. GAATAGTATGTCTCCTGGT; 2. 1001 
GGTAACCTGAACAAGAATA; 3. GGACAAACTCAGACATTGT) 1002 
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 1003 
In utero electroporation 1004 
 DNA plasmids encoding either scrambled or Ash2l-targeting shRNA were diluted 1005 
to a final concentration of 3 µg/µl in PBS containing 0.1% fast green dye tracer. DNA 1006 
solution (1–2 μl) was unilaterally injected into a lateral ventricle of E14 embryos using a 1007 
glass pipette and positive pneumatic pressure. PBS soaked Tweezertrodes with 5 mm 1008 
electrode diameter (45-0489; BTX) were then positioned across the heads of the embryos 1009 
followed by five 44 volt square pulses lasting 50 ms each at 950 ms interval applied using 1010 
a pulse generator (ECM830; BTX).  1011 
 1012 
Statistical analysis and computational analysis 1013 
All statistical analyses were accomplished using SPSS (IBM, Inc.). Shapiro-Wilks 1014 
test of normality and the Kolmogorov-Smirnov Test were conducted to test for normal 1015 
distribution. Levene’s test was conducted for homogeneity variance. Differences in 1016 
fractional anisotrophy (FA) were analyzed by two-tailed t tests.  One-way ANOVA with 1017 
repeated mesures or two-way ANOVA were conducted on the test sholl analysis of 1018 
nicotine-mediated or IUE-induced morphological changes. One-way ANOVA, followed 1019 
by Tukey or LSD test for multiple comparisons, was used to analyze experiments 1020 
confirming changes in mRNA and protein levels in independent samples. Fold-change in 1021 
ChIP (H3K4m3) experiments was analyzed by one-way ANOVA. A supplementary 1022 
methods checklist is available with complete statistical details of all experiments. 1023 
 1024 
Passive avoidance behavior 1025 
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Passive avoidance testing was conducted at 21 days of age in a step-through, two 1026 
chamber apparatus (Ugo Basile, Comerio, Italy) using a 3-day paradigm 24. Day 1: mice 1027 
were allowed to explore the apparatus for 5 min. Day 2: mice were placed in the light 1028 
chamber and received a mild, inescapable footshock (0.2 mA, 2s) after entry into the dark 1029 
chamber. Day 3: mice were placed in the light chamber and time to cross into the dark 1030 
chamber was measured. Latency to cross was measured on days 2 (training day) and 3 1031 
(testing day), with 5 min maximum. Passive avoidance studies were performed by an 1032 
investigator blinded to condition. Both male and female mice were used for passive 1033 
avoidance behavior and no sex differences were observed, as has been published 1034 
previously. No animals were excluded from analysis in studies of passive avoidance 1035 
behavior. No statistical methods were used to pre-determine sample sizes, but sample 1036 
sizes are similar to those reported in previous publications 24.  1037 
 1038 
Data Availability 1039 
H3K4me3 ChIP-seq and microarray datasets have been deposited in the GEO database at 1040 
NCBI. All datasets for this study are available under a single accession number: 1041 
GSE80789. Original Western blots are available in supplementary Figure 7. Gene 1042 
Ontology data are available in supplementary Tables 1-4. Statistical analyses for all 1043 
experiments are detailed in the Figure Legends and in the supplementary Data Checklist. 1044 
All data that support the findings of this study are available from the corresponding 1045 
author upon request. 1046 
 1047 
1048 
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Supplementary Figure 1 
Effects of nicotine exposure from birth to 3 weeks of age on dendritic complexity across cortical regions assessed at 3 months of age. 
(a-c) Sholl analysis of the apical dendritic tree in frontal (F), parietal (P) and occipital (O) regions of cortex. Exposure to nicotine in the
postnatal period significantly increased dendritic complexity across cortical regions. (a) F(1,80)=6.901, p=0.010321. (b) F(1,30)=16.525; 
p = p=0.0000001. (c) F(1,65)=32.586, p=p=0.000319. (d-f) Layer-specific effects of postnatal-only nicotine exposure on dendritic 
complexity in superficial (1/2), intermediate (3/4) and deep (5/6) layers of cortex. (d) F(1,20) = 5.625, p=0.027854. (e) F(1,46)=13.719, 
p=0.000565. (f) F(1, 23)=10.746, p=0.003299. *, p < 0.05. F: Sac, n=28; Nic, n=54; P: Sac, n=36; Nic, n=31; O: Sac, n=20; Nic, n=12;
1/2: Sac, n=9; Nic, n=13; 3/4: Sac, n=18, Nic, n=30; 5/6: Sac, n=10. Nic, n=15. 
Supplementary Figure 2 
Volcano plot showing all probe sets evaluated in the microarray study. 
(a) Genes whose expression levels were significantly different between developmentally nicotine exposed animals and controls are shown as red dots. 
(b) 6 of 15 probe sets were significantly altered in independent samples at 3 months of age following nicotine treatment throughout the pre- and 
postnatal period compared to the control group: F(1,8)=7.77 for Ash2l, p=0.02365035; F(1,8)=6.797 for Chsy3, p=0.03127061; F(1,8)=0.64 for Zfp91, 
p=0.44681333; F(1,8)=0.41 for Cflar, p=0.53987164; F(1,8)=26.538 for Zcchc11, p=0.00087271; F(1,8)=5.18 for Cep192, p=0.05240060; F(1,8)=1.24 
for Alkbh1, p=0.29780695; F(1,8)=0.72 for Gmeb1, p=0.42080639; F(1,8)=0.36 for Unc13b, p=0.56511006; F(1,8)=0.035 for Duox1, p=0.85625319; 
F(1,8)=8.82 for Scula2, p=0.01787528; F(1,8)=1.84 for Zfp597, p=0.21198878; F(1,8)=1.18 for Ctnnal1, p=0.30899997; F(1,8)=0.65 for Ntrk, 
p=0.44341660; F(1,8)=7.397 for Tmem107, p=0.02625917. (*p <0.05 and *** p <0.01 with multiple comparisons, and # p <0.05). 2 to 4 animals were 
pooled for each biological replicate. Five Biological replicates were used for each condition (Sac: n = 5; Nic: n = 5).  A total of 26 animals were used 
(Sac: n = 14;Nic: n = 12). 
Supplementary Figure 3 
Changes in H3K4me3 associated with the promoter sites of multiple gene loci following developmental nicotine exposure. 
(a) Gene ontology (GO) analysis identified significantly regulated gene groups, all of which are related to glutamatergic synaptic function. (b) Gene 
structure and coordination of Ank1 loci associated with H3K4me3 depicted in Fig. 3c. (c) Whisker plot showing verification of changes in histone 
H3Me3K4 levels associated with gene loci identified in the ChIP-seq analysis by ChIP-PCR in independent samples from subjects treated with nicotine 
from birth to 21 days (postnatal-only) and evaluated at 3 months of age: F(1,8)= 11.02for Eif4a, p= 0.01054575; F(1,8)= 6.028for Izumo, p= 0.03961426; 
F(1,8)= 1.406 for Gpr19, p= 0.26974334; F(1,8)= 21.7 for Litaf, p= 0.00162698; F(1,8)= 15.839 for kcnq1, p= 0.00406270; F(1,8)= 19.147 for Lage3, p=
0.00236227; F(1,8)=17.512 for Fbxw4, p= 0.00305973; F(1,8)= 16.594 for Fgf12, p= 0.00356573; F(1,8)= 77.18 for Sepsecs, p= 0.00002212; F(1,8)=
9.979 for Rin2, p= 0.01341607; F(1,8)= 64.634 for Rabgap1l, p= 0.00004215; F(1,8)= 81.61 for Ano2, p= 0.00001803; F(1,8)= 17.505 for Apool, p=
0.00306323; F(1,8)= 99.602for Lipc, p= 0.00000862; F(1,8)= 45.502 for Cdk5rap, p= 0.00014572; F(1,8)= 565.869 for Ing4 , p= 0.00000001; F(1,8)=
118.256 for Ank3, p= 0.00000452; F(1,8)= 43.276 for Ntm,  p= 0.00017324; F(1,8)= 487.52 for Zfp658, p= 0.00000002; F(1,8)= 8.77 for csda, p=
0.01810693; F(1,7)= 41.57 for Sorcs1, p= 0.00019884; F(1,8)=153.564 for Lars2, p= 0.00000168; F(1,8)= 50.843 for Ank1, p= 0.00009898; F(1,8)=
242.093 for Acacb, p= 0.00000029; F(1,8)= 223.283 for Mgda2, p= 0.00000040; F(1,8)= 110.084 for Chl1, p= 0.00000592; F(1,8)= 23.981 for Auts2, p=
0.00119824; F(1,8)= 0.483 for Mbnl1, p= 0.50674655; F(1,8)=10.846 for Cpeb1, p= 0.01096747; F(1,8)= 15.121 for Zfp71-rs1, p= 0.00461852; F(1,8)=
5.928 for Chd9, p= 0.04089817; F(1,8)= 24.034 for Syt4, p= 0.00119008; F(1,8)=7.836 for Sp110, p= 0.02322340; F(1,8)= 51.276for Sorbs2, p=
0.00009607; F(1,8)= 24.889 for Slc35a2, p= 0.00106755; F(1,8)= 19.501 for Mef2c, p= 0.00223843 (*p <0.05 and *** p <0.01 with multiple comparison, 
and # p <0.05). Each replicate was a pool of 2-4 brain samples and 5 replicates were used for each condition (Sac: n = 5 pools from 14 animals; Nic: n =
5 pools from 12 animals). (d) Ash2l and Mef2c binding sites overlap with sites of H3K4me3 enrichment. Among these, GO analysis of 108 genomic sites
identified as differentially enriched following nicotine exposure reveals that overlapped genomic sites are associated with synapse related functions. 
Supplementary Figure 4 
Regulation of Mef2c locus by nicotine treatment in vivo. 
(a) Mef2c mRNA levels were significantly elevated at 21 days of age, immediately after nicotine exposure was completed
F(1,8)=19.237, p=0.00232999. 5 Biological replicates per each condition from pooled female animals; Nic = 11 Sac = 15. (b) Histone 
H3 acetylation associated with the Mef2c locus was significantly increased as a result of nicotine exposure during development 
F(1,8)=118.802, p=0.00000445. 5 Biological replicates per each condition from pooled female animals; Nic = 12 Sac = 14. (c) Nicotine 
exposure during development significantly increased the level of H3K4me3 associated with the Mef2c locus (F(5,24)=10.403, 
p=0.000021) with Tukey's multiple comparison test.  Frontal sac vs Frontal nic, p=0.001277; Parietal sac vs Parietal nic, p=0.005846;
Occipital sac vs Occipital nic, p=0.011952. 5 Biological replicates per each condition from pooled female animals; Nic = 12 Sac = 12  
*p < 0.05  and *** p <0.01.  
Supplementary Figure 5 
Evaluation of shRNA-mediated knock down of Ash2l and Mef2c protein levels in neural progenitor cells. 
a) shRNA targeting Ash2l. b) shRNA targeting Mef2c. Original Western blots presented in supplementary Figure 8. 
Supplementary Figure 6 
Spread following in utero electroporation. 
Example of the extent of shRNA spread and of GFP expression in a layer 6 cortical pyramidal neuron following in utero electroporation 
of shRNAs. 
Supplementary Figure 7 
Original images of representative western blot images in Figure 4 and supplementary figure 6. 
(a-d)  indicate uncropped LICOR machine scanned gel image with annotation. (e) Scanned film image of Figure 4 immunopreciptiation 
experiment. (f-g) Nicotine induced Wdr5 and Rbbp5 expression blot: original scanned image from LICOR machine. (i-j) Scanned 
images from LICOR machine for shRNA knockdown efficiency experiment presented in supplementary Figure 6. 
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ID Gene Name FDR 
(pre&postnatal) 
FDR 
(postnatal) 
2210408I21Rik RIKEN cDNA 2210408I21 gene 8.93E-07 0.038155606 
A530032D15Rik RIKEN cDNA A530032D15Rik gene 0.038008176 2.09E-05 
Acacb acetyl-Coenzyme A carboxylase beta 1.07E-14 3.43E-05 
Ank1 ankyrin 1, erythroid 6.76E-08 0.037369502 
Ank3 ankyrin 3, epithelial 0.025089193 0.03170677 
Ano2 anoctamin 2 5.40E-18 4.32E-07 
Apool apolipoprotein O-like 0.001118347 0.016145928 
Atus2 autism susceptibility candidate 2 5.36E-16 0.000136714 
C130026I21Rik  similar to SP140 nuclear body protein family member 0.021802715 0.000372029 
Cdk5rap2 CDK5 regulatory subunit associated protein 2 1.78E-07 0.047926553 
Chd9 chromodomain helicase DNA binding protein 9 0.048521886 0.002718363 
Chl1 cell adhesion molecule with homology to L1CAM 4.67E-09 1.51E-11 
Cpeb1 cytoplasmic polyadenylation element binding protein 1 0.042573761 0.040368177 
Csda cold shock domain protein A 1.06E-14 3.43E-05 
Eif4a2 eukaryotic translation initiation factor 4A2 0.044916064 0.036176643 
Fbxw4 F-box and WD-40 domain protein 4 0.033310937 0.000184038 
Fgf12 fibroblast growth factor 12 0.039388541 0.000184038 
Gpr19 G protein-coupled receptor 19 0.037900534 0.038098746 
Ing4 inhibitor of growth family, member 4 0.02856405 0.02847679 
Izumo1 izumo sperm-egg fusion 1 3.56E-16 5.68E-06 
Kcnq1 potassium voltage-gated channel, subfamily Q, member 
1 
1.14E-05 0.04566623 
Lage3 L antigen family, member 3 0.029330973 0.003353947 
Lars2 leucyl-tRNA synthetase, mitochondrial 0.00103869 0.010982124 
Lipc lipase, hepatic 9.43E-06 1.17E-05 
Litaf LPS-induced TN factor 1.06E-05 0.015501719 
Mbnl1 muscleblind-like 1 (Drosophila) 0.014790903 0.012125092 
Mdga2 MAM domain containing glycosylphosphatidylinositol 
anchor 2 
3.74E-11 0.017296099 
Mef2c myocyte enhancer factor 2C 0.008353399 0.002577155 
Ntm neurotrimin 0.011985522 0.044375612 
Rabgap1l RAB GTPase activating protein 1-like 0.044469567 0.001785805 
Rin2 similar to Ras and Rab interactor 2; Ras and Rab 
interactor 2 
4.61E-09 2.11E-08 
Sepsecs Sep (O-phosphoserine) tRNA 6.53E-07 0.00153469 
Slc35a2 solute carrier family 35 (UDP-galactose transporter), 
member A2 
0.007163381 0.006114679 
Sorbs2 sorbin and SH3 domain containing 2 0.003283078 0.000776979 
Sorcs1 VPS10 domain receptor protein SORCS 1 0.001037955 0.009029728 
Sp110 predicted gene 15753; Sp110 nuclear body protein 0.003851627 0.001195924 
Syt4 synaptotagmin IV 0.013634086 0.037736076 
Zfp658 cDNA sequence BC043301 0.013288823 0.012528656 
Zfp71-rs1 zinc finger protein 71, releated sequence 0.041686509 0.034138712 
 
Supplementary Table 1. 39 common gene loci identified from pre & postnatal nicotine and 
postnatal nicotine treated group (adj.p<0.05) 
ID Gene Name FDR 
(pre&postnatal) 
FDR 
(postnatal) 
2210408I21Rik RIKEN cDNA 2210408I21 gene 8.93E-07 0.038155606 
A530032D15Rik RIKEN cDNA A530032D15Rik gene 0.038008176 2.09E-05 
Acacb acetyl-Coenzyme A carboxylase beta 1.07E-14 3.43E-05 
Adam12 a disintegrin and metalloproteinase domain 12 (meltrin 
alpha) 
6.76E-08 0.037369502 
Aldh1b1 aldehyde dehydrogenase 1 family, member B1 0.065952838 0.088568177 
Ank1 ankyrin 1, erythrocytic 6.76E-08 0.037369502 
Ank3 ankyrin 3, node of Ranvier (ankyrin G) 0.025089193 0.03170677 
Ano2 anoctamin 2 5.40E-18 4.32E-07 
Apool apolipoprotein O-like 0.001118347 0.016145928 
Atp5g1 ATP synthase, H+ transporting, mitochondrial F0 
complex, subunit C1 (subunit 9) 
0.079697042 0.079697042 
Atrnl1 attractin-like 1 1.49E-05 0.080044326 
AU015836 expressed sequence AU015836 0.050596023 0.01451473 
Auts2 autism susceptibility candidate 2 5.36E-16 0.000136714 
C130026I21Rik RIKEN cDNA C130026I21 gene 0.021802715 0.000372029 
Cdc73 Cell division control protein 73 0.073836761 0.088726114 
Cdk5rap2 CDK5 regulatory subunit associated protein 2 1.78E-07 0.047926553 
Chd9 chromodomain helicase DNA binding protein 9 0.048521886 0.002718363 
Chl1 cell adhesion molecule with homology to L1CAM 4.67E-09 1.51E-11 
Cpeb1 cytoplasmic polyadenylation element binding protein 1 0.042573761 0.040368177 
Csda cold shock domain protein A 1.06E-14 3.43E-05 
D6Wsu163e DNA segment, Chr 6, Wayne State University 163, 
expressed 
0.071347961 0.04566623 
Dlg2 discs, large homolog 2 0.057139925 0.049376395 
Eif4a2 eukaryotic translation initiation factor 4A2 0.044916064 0.036176643 
Elavl2 ELAV (embryonic lethal, abnormal vision)-like 2 (Hu 
antigen B) 
0.004157577 0.051964561 
Fam19a3 family with sequence similarity 19 (chemokine (C-C 
motif)-like), member A3 
0.08058543 0.002718363 
Fastkd2 FAST kinase domains 2 0.055335149 0.077897659 
Fbxw4 F-box and WD repeat domain containing 4 0.033310937 0.000184038 
Fgf12 fibroblast growth factor 12 0.039388541 0.000184038 
Gas8 growth arrest-specific 8 0.097730225 0.063671548 
Glis3 GLIS family zinc finger 3 0.088618788 0.004125082 
Gm13152 predicted gene 13152 0.037492077 0.062014274 
Gpr19 G protein-coupled receptor 19 0.037900534 0.038098746 
Hdac10 histone deacetylase 10 0.075936628 0.061014668 
Ing4 inhibitor of growth family, member 4 0.02856405 0.02847679 
Izumo1 izumo sperm-egg fusion 1 3.56E-16 5.68E-06 
Kcnq1 potassium voltage-gated channel, KQT-like subfamily, 
member 1 
1.14E-05 0.04566623 
Lage3 L antigen family, member 3 0.029330973 0.003353947 
Lars2 leucyl-tRNA synthetase 2, mitochondrial 0.00103869 0.010982124 
Lipc lipase, hepatic 9.43E-06 1.17E-05 
Litaf lipopolysaccharide-induced TNF factor 1.06E-05 0.015501719 
Lrrtm4 leucine rich repeat transmembrane neuronal 4 0.093643174 0.030674136 
Macrod2 MACRO domain-containing protein 2 0.029330973 0.058068612 
Mapk10 mitogen-activated protein kinase 10 0.0029967 0.08626202 
Mbnl1 muscleblind-like 1 (Drosophila) 0.014790903 0.012125092 
Mdga2 MAM domain containing glycosylphosphatidylinositol 
anchor 2 
3.74E-11 0.017296099 
Mef2c myocyte enhancer factor 2C 0.008353399 0.002577155 
Ncoa1 nuclear receptor coactivator 1 0.058187811 4.76E-05 
Ngdn neuroguidin, EIF4E binding protein 0.092853631 0.077296869 
Nmt1 Glycylpeptide N-tetradecanoyltransferase 0.019774984 0.093523028 
Npffr2 neuropeptide FF receptor 2 0.013729635 0.097636892 
Ntm neurotrimin 0.011985522 0.044375612 
Pank1 pantothenate kinase 1 0.079488186 0.090827981 
Pisd-ps1 phosphatidylserine decarboxylase, pseudogene 1 0.095486187 0.003564612 
Ppil2 peptidylprolyl isomerase (cyclophilin)-like 2 0.034451154 0.087426372 
Prickle2 prickle homolog 2 (Drosophila) 0.051082201 0.08177247 
Psd3 pleckstrin and Sec7 domain containing 3 0.093039972 0.062014274 
Rabgap1l RAB GTPase activating protein 1-like 0.044469567 0.001785805 
Rin2 Ras and Rab interactor 2 4.61E-09 2.11E-08 
Sepsecs Sep (O-phosphoserine) tRNA:Sec (selenocysteine) 
tRNA synthase 
6.53E-07 0.00153469 
Sh3pxd2a SH3 and PX domains 2A 0.07258674 0.070588595 
Slc35a2 solute carrier family 35 (UDP-galactose transporter), 
member A2 
0.007163381 0.006114679 
Sorbs2 sorbin and SH3 domain containing 2 0.003283078 0.000776979 
Sorcs1 sortilin-related VPS10 domain containing receptor 1 0.001037955 0.009029728 
Sp110 Sp110 nuclear body protein 0.003851627 0.001195924 
Sumf2 sulfatase modifying factor 2 0.003851627 0.049635918 
Syt4 synaptotagmin IV 0.013634086 0.037736076 
Taz tafazzin 0.09617633 0.003253765 
Wdr34 WD repeat domain 34 0.058187811 0.040777754 
Wwc2 WW and C2 domain containing 2 0.025783257 0.067486457 
Zfp658 cDNA sequence BC043301 0.013288823 0.012528656 
Zfp71-rs1 zinc finger protein 71, releated sequence 0.041686509 0.034138712 
Spag17-ps sperm associated antigen 17 pseudogene 0.003680777 0.064997816 
Rbfox2 RNA binding protein, fox-1 homolog 8.10E-05 0.086608937 
 
Supplementary Table 2.  73 common gene loci identified from pre & postnatal 
nicotine and postnatal nicotine treated group (adj.p<0.05) 
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Ank3 Ankyrin 3 X
Caly Calcyon neuron-specific vesicular protein X
Camk2a Calcium/calmodulin-dependent protein kinase II alpha X X X X
Chrm1 Cholinergic receptor, muscarinic 1 X X X X X
Cldn23 claudin 23 X X
Cog4 component of oligomeric golgi complex 4 X
Cpeb1 cytoplasmic polyadenylation element binding protein 1 X X X X X X
Csda Cold-shock domain protein A X X
Dlg2 discs, large homolog 2 ( Drosophila) X X X X X X
Dlgap2 discs, large ( Drosophila) homolog-associated protein 2 X X X X X X
Dnmbp dynamin binding protein X X X X
Ephbp3 EPH receptor B3 X
Gabra1 gamma-aminobutyric acid (GABA) A receptor, alpha 1 X X X X X
Gria3 glutamate receptor, ionotropic, AMPA 3 X X X X X X
Grin1 glutamate receptor, ionotropic, N-methyl D-aspartate 1 (Zeta 1) X X X X X X
Kcnq1 potassium voltage-gated channel, KQT-like subfamily, member 1 X
Kctd16 potassium channel tetramerization domain containing 16 X
Litaf lipopolysaccharide- induced TNF factor X
Lrrk2 leucine-rich repeat kinase 2 X X
Magi2 membrane associated guanylate kinase, WW and PDZ domain contain X X X
Npffr2 neuropeptide FF receptor 2 X
Ppt1 palmitoyl-protein thioesterase 1 X X
Prickle2 prickle homolog 2 ( Drosophila) X
Psd3 pleckstrin and Sec7 domain containing 3 X X X X X X
Rab3c member RAS oncogene family X X X
Rims2 regulating synaptic membrane exocytosis 2 X X X
Shroom4 shroom family member 4 X
Slc4a10 solute carrier family 4, sodium bicarbonate transporter, member 10 X
Speed2 sprouty-related, EVH1 domain containing 2 X
Syt4 synaptotagmin IV X X X X
Sytl2 synaptotagmin-like 2 X
Tnfaip1 tumor necrosis factor, alpha-induced protein 1 (endothelial) X
Vwf  von Willebrand factor 2 X
Xirp2 xin actin-binding repeat containing 2 X
Gene Ontology Group
Supplementary Table 3. Significant Gene Ontology Groups for H3MeK4 sequencing data of tissue from pre- and 
postnatal nicotine treated subjects.
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Alk anaplastic lymphoma receptor tyrosine kinase X
Anks1b ankyrin repeat and sterile alpha motif domain containing 1B X X X X X X
Arhgef2 ADP-ribosylation factor guanine nucleotide-exchange factor 2 X X
Cacnb4 calcium channel, voltage-dependent, beta 4 subunit X
Cdh13 cadherin 13 (T-cadherin) X
Cdh4 Cadherin 4 X
Chrna3 cholinergic receptor, nicotinic, alpha 3 (neuronal) X X X X X X
Cpeb1 cytoplasmic polyadenylation element binding protein 1 X X X X X X
Csda Cold-shock domain protein A X X
Ctnna1 catenin (cadherin- associated protein), alpha 1 X X
Cybrd1 cytochrome b reductase 1 X
Dlg2 discs, large homolog 2 ( Drosophila) X X X X X X
Dsc1 desmocollin 1 X X
Fblim1 filamin binding LIM protein 1 X X
Fmn1 formin 1 X X
Fn1 fibronectin 1 X
Grid2ip glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein X X X X X X
Grin2c glutamate receptor, ionotropic, N-methyl D-aspartate 2C X X X X X X
Grin2d glutamate receptor, ionotropic, N-methyl D-aspartate 2D, X X X X X X
Grip1 glutamate receptor interacting protein 1 X X X X X
Kcnq1 potassium voltage-gated channel, KQT-like subfamily, member 1 X
Lmo7 LIM domain only 7 X
Magi1 membrane associated guanylate kinase, WW and PDZ domain containing 1 X
Mmp16 matrix metallopeptidase 16 (membrane-inserted) X
Mt3 metallothionein 3 X X X X X X
Npffr2 neuropeptide FF receptor 2 X X
Odz3 Oz/ten-m homolog 3 (Drosophila) X X X
Prickle2 prickle homolog 2 ( Drosophila) X X
Psd3 pleckstrin and Sec7 domain containing 3 X X X X X X
Pvrl4 poliovirus receptor-related 4 X X
Rimbp2 Rims binding protein 2 X X X
Scn1a sodium channel, voltage -gated, type I, alpha subunit X X
Shank2  SH3 and multiple ankyrin repeat domains 2 X X X X X X
Slc2a3 solute carrier family 2 (facilitated glucose transporter), member 3 X
Slc4a4 solute carrier family 4 ( sodium bicarbonate cotransporter), member 4 X
Sorbs3 sorbin and SH3 domain containing 3 X X
Spred2 sprouty-related, EVH1 domain containing 2 X
Syt4 synaptotagmin IV X X X X
Utrn Utrophin X X X
Vmn1r81 vomeronasal 1 receptor 81 X
Gene Ontology Group
Supplementary Table 4. Significant Gene Ontology Groups for H3MeK4 sequencing data of tissue from postnatal-only 
nicotine treated subjects.
 
ChIP-PCR primers (H3K4me3) 
 
ChIP-PCR primers (Control GAPDH H3K4me3) 
 
Target Forward Reverse 
Gapdh (1) 5'-ccctcgaactaaggggaaag-3' 5'-ttccatcctccagaaaccag-3' 
Gapdh (2) 5'-acatcacccccatcactcat-3' 5'-tccccttagttcgagggact-3' 
Target Forward Reverse 
Acacb 5'-ggaaggtgactcatgcctgt-3' 5'-gagcagtcgggtgctcttac-3' 
Ank1 5'-ctcgtggccatttttcctaa-3' 5'-cccgctgcagtaagttcttc-3' 
Ank3 5'-cctcagtggattctgggaga-3' 5'-aacacttggggcagaacatc-3' 
Ano2 5'-ccagtggcttccgattgtat-3' 5'-gaatggaatggagcaggcta-3' 
Apool 5'-ttaatccctgcgggtaactg-3' 5'-ttttgtctgttttgcccaca-3' 
Auts2 5'-ccaagttgagcctctggttt-3' 5'-gatcctaaacggcagcagag-3' 
Cdk5rap2 5'-ataggccgaggtgcagtaga-3' 5'-ccaccccatttgtacctgtc-3' 
Chd9 5'-gaacaaatgtacgccctcgt-3' 5'-atgacatcaaccctgccttc-3' 
Chl1 5'-ccttgcttgaaagattgcttg-3' 5'-cctgaattgttagccgcaat-3' 
Cpeb1 5'-gcttggataccttgcctctg-3' 5'-cagaggtggggaaaagcat-3' 
Csda 5'-tccagatttgttgcaggtga-3' 5'-tagccctcctttaggccttc-3' 
Eif4a2 5'-gactccagatgttggggaga -3' 5'-cccatctcgacagaacccta -3' 
Fbxw4 5'-taactgcggagccatctctt-3' 5'-cggcctccactcactagaag-3' 
Fgf12 5'-tcacacgttttgttgccact-3' 5'-gatcaaggagctggctatcg-3' 
Gpr19 5'-agcacgagagggaaagaa-3'ca 5'-tgcttggctgctgtgttatc-3' 
Ing4 5'-ctcgctgtagatgaccgtga-3' 5'-aatacatcccagcagccatc-3' 
Izumo1 5'-acgtggaagtcctgaccatc-3' 5'-cctgtctgggctagcatttc-3' 
Kcnq1 5'-cccactttctctcagccttg-3' 5'-aaaacgggcaagagagttga-3' 
Lage3 5'-aatccctggagagtcctcct-3' 5'-tgctgttcctcctttcaacc-3' 
Lars2 5'-gctgtacctgtgccaaacct-3' 5'-agcagcttcatgcctagctc-3' 
Lipc 5'-agaggccggaggattactgt-3' 5'-cttgagcccagaagtccaag-3' 
Litaf 5'-gcagatgctgggtatcgttt-3' 5'-agatggctctgctggtctgt-3' 
Mbnl1 5'-accaaactccatcgcaaatc-3' 5'-tcagccgtgtgctcagtaac-3' 
Mdga2 5'-attacgagggctgggaagtt-3' 5'-aaaatgccagcacagaaacc-3' 
Mef2c 5'-acacacgcacacttcgtctc -3' 5'-gccttgaagtgcttctccac -3' 
Rabgap1l 5'-ctgccgggagattctttaca-3' 5'-aggaggaccgagtcaccttt-3' 
Rin2 5'-ccatgatattccacccaagg-3' 5'-tcttttccctggggtttctt-3' 
Sepsecs 5'-tgggactatttcaggccaac-3' 5'-gctgattttggaagcctgag-3' 
Slc35a 5'-ggagcaacggaaccaataaa-3' 5'-attctcaaatggtggcttcg-3' 
Sorbs2 5'-gcggttatccaactgcatct-3' 5'-ttcctccctgaaaacgtcac-3' 
Sorcs1 5'-attaaacgcgtcaagcacct-3' 5'-cgtgtcttcagcttccttcc-3' 
Sp110 5'-ttgcctggtcctctcactct -3' 5'-gtatcaccgcaggatgtgtg -3' 
Syt4 5'-tgcttttggcctcgtcttca-3' 5'-gcggttttacccttcacttcac-3' 
Zfp658 5'-ggccatgacagctcctaaa-3'g 5'-atatgaccgctcgagaccac-3' 
Zfp71-rs1 5'-ccgaactcctttggtgtgtt-3' 5'-atccaaacccaagacactcg-3' 
 
 
ChIP-PCR primers (Acetylation) 
 
Target Forward Reverse 
Mef2c 5'-cacgcatctcaccgcttgacg-3' 5'-caccagtgcctttctgcttctcc-3' 
 
 
 
 
qRT-PCR primer list 
 
Target Forward Reverse 
Ash2L 5'-ccgaaagtggggatgcaaact-3' 5'-gtcagcggtgaaccattttgt-3' 
Cep192 5'-aaggtggatctttcaacacagac-3' 5'-cgataacaggggtttcagcaat-3' 
Cflar 5'-cagaggcaagatagccaagg-3' 5'-tggatgttcttcaggctttt-3' 
Chsy3 5'-agtctttgctcctactacggc-3' 5'-gtcccgaaaactgggacct-3' 
Ctnnal1 5'-tcttctgcccctggtttctca-3' 5'-cctgtcccacacgctgaat-3' 
Duox1 5'-aaaacaccaggaacggattgt-3' 5'-agaagacattgggctgtaggg-3' 
Gmeb1 5'-gagaacccggaagacactaaaac-3' 5'-ggctacaactgctgcgctat-3' 
Nrp 5'-tgggagccgtcatcgactt-3' 5'-gctcgacattacagctcactg-3' 
Ntrk2 5'-ctggggcttatgcctgctg-3' 5'-aggctcagtacaccaaatccta-3' 
Sucla2 5'-accctttcgctgcatgaatac-3' 5'-cctgtgcctttatcacaacatcc-3' 
Tmem107 5'-aattcaccccggaggaatacg-3' 5'-agggtttctttttcagcccaa-3' 
Unc13b 5'-ccagaacgtgaagagcacaa-3' 5'-cagtcccttgttccacacct-3' 
Zcchc11 5'-agagtgaacttcgtctcttcc-3' 5'-aaccatacaacctcagtgaacattc-3' 
Zfp597 5'-agcagagaagccccattgaag-3' 5'-tcagagtagtgaacaacgggt-3' 
Zfp91 5'-gacctctatctctcgccttcg-3' 5'-aaggagccagtcttggaccta-3' 
 
 
 
Target Forward Reverse 
Mef2c 5'-atcccgatgcagacgattcag-3' 5'-aacagcacacaatctttgcct-3' 
Gapdh 5'-aggtcggtgtgaacggatttg-3' 5'-tgtagaccatgtagttgaggtca-3' 
 
pAAV-shRNA cloning primer 
 
Target Forward Reverse 
pAAV-shRNA 5'-cccctgaacctgaaacataaa-3' 5'-cacagacttgtgggagaagc-3' 
 
Supplementary Table 5.  Primer list used in ChIP-PCR, qRT-PCR, and cloning 
 
